SurePath™ Pap with Reflex to HPV mRNA E6/E7
Test Code
Clinical Significance
SurePath™ Pap with Reflex to HPV mRNA E6/E7 - Liquid based pap testing is intended for use in the screening and detection of cervical cancer, pre-cancerous lesions, atypical cells and all other cytologic categories as defined by the bethesda system for reporting results of cervical cytology. Pap screening is not reliable for the detection of endometrial cancer.
Test Resources
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.
Test Details
Pap results requiring physician interpretation will be performed at an additional charge (CPT code(s): 88141; HCPCS: G0124)
For Interpretations of Atypical Squamous Cells (ASC), HPV mRNA, High Risk will be performed at an additional charge (CPT code(s): 87624).
Methodology
Reference Range(s)
Alternative Name(s)
Preferred Specimen(s)
Pap sample collected in 1 SurePath™ pap vial
Minimum Volume
1 SurePath pap vial
Collection Instructions
For instructions refer to
//www.questdiagnostics.com/dms/Documents/Other/Specimen_Collection_and_Transport_Guide_2019.pdf
Transport Container
1 SurePath pap vial
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 7 days
- Refrigerated: 7 days
- Frozen: Unacceptable
- Refer to local service area for specimen retention
Reject Criteria
SurePath vials without the head of the collection device(s) in the fluid • Swabs • SurePath vials received frozen • Cervical swabs in Digene® HC cervical sampler • Digene® vials
Setup Schedule
//www.questdiagnostics.com/dms/Documents/Other/Specimen_Collection_and_Transport_Guide_2019.pdf
Refrigerated: 7 days
Frozen: Unacceptable
Refer to local service area for specimen retention